Supernus Pharmaceuticals Down Nearly 18%, On Track for Largest Percent Decrease Since November 2019 -- Data Talk

Dow Jones11-06

Supernus Pharmaceuticals, Inc. ( SUPN ) is currently at $46.80, down $10.20 or 17.89%

 

--Would be lowest close since Sept. 19, 2025, when it closed at $46.04

--On pace for largest percent decrease since Nov. 6, 2019, when it fell 31.58%

--Snaps a two day winning streak

--Up 29.44% year-to-date; on pace for best year since 2017, when it rose 57.82%

--Down 21.8% from its all-time closing high of $59.85 on June 29, 2018

--Up 23.99% from 52 weeks ago (Nov. 6, 2024), when it closed at $37.75

--Down 17.89% from its 52-week closing high of $57.00 on Nov. 4, 2025

--Up 54.52% from its 52-week closing low of $30.29 on April 21, 2025

--Traded as low as $43.11; lowest intraday level since Aug. 21, 2025, when it hit $42.67

--Down 24.37% at today's intraday low; largest intraday percent decrease since Nov. 6, 2019, when it fell as much as 33.57%

 

All data as of 11:45:47 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 05, 2025 11:52 ET (16:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment